Isolator Decontamination Using Chlorine Dioxide Gas

The authors argue that chlorine dioxide (CD) is a safe and effective decontaminating agent that can be used for challenging applications.The effectiveness of CD gas for sterilizing complex isolator systems is studied.

Articles in this issue

---

Analytical Methods Validation In-Process Control Methods for the Manufacture of Active Pharmaceutical Ingredients

April 2005

Management Controls for GMP Compliance

The Sector Chart: A New Engineering Graph for Pharmaceutical Processes

Validation of Alternative Microbiology Methods for Product Testing Quantitative and Qualitative Assays

PAT and Process Understanding: A Call to Arms

Cold Chain Concerns

Evolutions in Direct Compression

X-ray Microtomography of Solid Dosage Forms

Orient Express

Importance of Background Microbial Levels in the Manufacture and Testing of Sterile Products

Using Visible Residue Limits for Introducing New Compounds into a Pharmaceutical Research Facility

Comparative Evaluation of Three Active Air Samplers for the Monitoring of Airborne Microorganisms

Famine in Field Inspection

Establishing Target Fills for Semisolid and Liquid Dosage Forms

Related Videos

Related Content

Advertisement

July 28th 2025

Boehringer Ingelheim, Re-Vana Therapeutics to Collaborate on Long-Acting Ophthalmic Therapies

Patrick Lavery

Re-Vana’s drug delivery technology is designed to release treatments over a 6- to 12-month period, with the goal of reducing frequency of injections for patients.

June 25th 2024

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

July 28th 2025

GSK and Hengrui Pharma Collaborate on Drug Development

Susan Haigney

The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.

April 30th 2024

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

July 25th 2025

EMA Approves Lower GWP Alternative for Inhalation Medicine

Susan Haigney

The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava Aerosphere that will have a 1000-fold reduction in global warming potential compared to the current propellant.

July 25th 2025

CMC and Analytical Gaps in CRLs: Why They Persist Despite FDA Guidance and How You Can Position Yourself for Success

Christopher Cole

Many companies face FDA complete response letters due to ongoing chemistry, manufacturing, and controls, or CMC, and analytical issues despite early regulatory guidance. Review key risk points in analytical and tech transfer to better ensure commercial readiness.

Related Content

Advertisement

July 28th 2025

Boehringer Ingelheim, Re-Vana Therapeutics to Collaborate on Long-Acting Ophthalmic Therapies

Patrick Lavery

Re-Vana’s drug delivery technology is designed to release treatments over a 6- to 12-month period, with the goal of reducing frequency of injections for patients.

June 25th 2024

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

July 28th 2025

GSK and Hengrui Pharma Collaborate on Drug Development

Susan Haigney

The two companies have entered into an agreement to develop respiratory, immunology, inflammation, and cancer therapies.

April 30th 2024

Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines

Feliza Mirasol

In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.

July 25th 2025

EMA Approves Lower GWP Alternative for Inhalation Medicine

Susan Haigney

The agency has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava Aerosphere that will have a 1000-fold reduction in global warming potential compared to the current propellant.

July 25th 2025

CMC and Analytical Gaps in CRLs: Why They Persist Despite FDA Guidance and How You Can Position Yourself for Success

Christopher Cole

Many companies face FDA complete response letters due to ongoing chemistry, manufacturing, and controls, or CMC, and analytical issues despite early regulatory guidance. Review key risk points in analytical and tech transfer to better ensure commercial readiness.